Seneschal Advisors
DXCM icon

Seneschal Advisors’s DexCom DXCM Stock Holding History

Seneschal Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$432 Buy
5
+2
+67% +$166 ﹤0.01% 451
2026
Q2 		$203 Sell
3
-2
-40% -$133 ﹤0.01% 539
2026
Q1 		$314 Buy
5
+3
+150% +$209 ﹤0.01% 468
2025
Q4 		$133 Sell
2
-1
-33% -$65 ﹤0.01% 560
2025
Q3 		$202 Buy
+3
New +$237 ﹤0.01% 533

Other funds holding DXCM

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Seneschal Advisors's DXCM Position: Q3 2026 in Review

Seneschal Advisors increased its DexCom (DXCM) stake by 67% in Q3 2026, buying an estimated $166 and bringing the position to 5 shares worth $432. The position accounts for ﹤0.01% of the portfolio, ranked #451.

Seneschal Advisors first reported a position in DXCM in Q3 2025 and has held it in 5 quarters since. 863 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Seneschal Advisors held 5 shares of DexCom worth $432 as of Q3 2026.
  • Seneschal Advisors bought 2 DexCom shares in Q3 2026, an estimated $166.
  • DexCom made up ﹤0.01% of Seneschal Advisors's portfolio in Q3 2026, its #451 holding.
  • Seneschal Advisors first reported a position in DexCom in Q3 2025 and has held it in 5 quarters since.
  • 863 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Seneschal Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.